PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation...
TEL AVIV, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3928 | -11.8242022878 | 3.322 | 3.69 | 2.81 | 112816 | 3.37240839 | CS |
4 | -0.2408 | -7.59621451104 | 3.17 | 16.63 | 2.16 | 6007130 | 10.70134025 | CS |
12 | 0.1856 | 6.76483452398 | 2.7436 | 16.63 | 1.7272 | 6288769 | 6.8123977 | CS |
26 | -8.718 | -74.8506078714 | 11.6472 | 16.63 | 1.7272 | 3490696 | 6.63884692 | CS |
52 | -56.3508 | -95.0587044534 | 59.28 | 63.12 | 1.7272 | 1820517 | 7.35462428 | CS |
156 | -325.8708 | -99.1091240876 | 328.8 | 633.84 | 1.7272 | 763332 | 50.91989795 | CS |
260 | -1597.8708 | -99.8170164918 | 1600.8 | 1881.6 | 1.7272 | 681401 | 238.15122123 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales